Top Markets
Coin of the day
BriaCell Therapeutics Corp. BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp.

BCTX
Rang in Aktien #18288
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages... BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
Aktienkurs
$4.32
Marktkapitalisierung
$8.14M
Veränderung (1 Tag)
-6.49%
Veränderung (1 Jahr)
-2.88%
Land
CA
Handel BriaCell Therapeutics Corp. (BCTX)

Kategorie

Kursverlauf für BriaCell Therapeutics Corp. (BCTX)
Höchster Schlusskurs: $4.42 am 2026-04-01

Niedrigster Schlusskurs: $75.68 am 2012-08-01
Kursverlauf der Aktie von BriaCell Therapeutics Corp. von 2012 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -39.84%
2025 1,135.43%
2024 -83.23%
2023 -12.56%
2022 -38.69%
2021 120.46%
2020 -59.87%
2019 -50.29%
2018 -42.32%
2017 -16.70%
2016 -13.38%
2015 9.99%
2014 82.35%
2013 -43.96%
2012 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$40.93 -34.91%
DK
$435.65 -10.34%
US
$746.00 35.81%
US
$306.86 95.16%
BE
$828.35 40.97%
NL